Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Liprin α3 Inhibitors

Liprin α3 inhibitors are chemical compounds designed to specifically inhibit the activity of the Liprin α3 protein, which is a member of the Liprin (LAR interacting protein) family. Liprins are scaffold proteins known for their involvement in regulating cytoskeletal dynamics, cell adhesion, and intracellular signaling pathways. Liprin α3, in particular, plays a crucial role in synaptic organization, vesicle trafficking, and cellular architecture. By inhibiting Liprin α3, these inhibitors can modulate key protein-protein interactions and signaling events that rely on Liprin α3's scaffold functions, altering cellular processes such as actin cytoskeleton rearrangement and membrane trafficking.

The chemical structure of Liprin α3 inhibitors typically allows them to bind selectively to specific domains of the Liprin α3 protein, preventing its interaction with other associated proteins or its participation in larger multi-protein complexes. This inhibition can disrupt Liprin α3-mediated processes, which are often involved in the organization of membrane proteins and vesicular components. These compounds can be particularly useful in studying the specific roles of Liprin α3 in cellular functions, helping to elucidate the molecular mechanisms behind synapse formation, cell polarity, and intercellular communication. Additionally, because Liprin α3 interacts with several signaling molecules, inhibiting its function can provide insights into various signal transduction pathways, allowing researchers to dissect the individual contributions of Liprin α3 in complex cellular environments.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D may inhibit Liprin-α3 expression by intercalating into DNA, preventing RNA synthesis and affecting transcription of Liprin-α3.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide might inhibit Liprin-α3 expression by blocking protein synthesis, thereby reducing the production of Liprin-α3 protein.

Chromomycin A3

7059-24-7sc-200907
10 mg
$255.00
(1)

Actinomycin C could potentially inhibit Liprin-α3 expression similarly to Actinomycin D, by interfering with RNA synthesis.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin may inhibit Liprin-α3 expression by targeting bacterial-like RNA polymerase, potentially affecting the transcription of Liprin-α3.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$163.00
$316.00
436
(1)

Puromycin might inhibit Liprin-α3 expression by prematurely terminating protein synthesis, thereby reducing Liprin-α3 production.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin has been suggested to inhibit Liprin-α3 expression by inhibiting protein synthesis at the translational level, affecting Liprin-α3 production.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin may inhibit Liprin-α3 expression by intercalating into DNA and impacting transcription, reducing the synthesis of Liprin-α3.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide could potentially inhibit Liprin-α3 expression by affecting topoisomerase II activity, influencing DNA transcription and Liprin-α3 synthesis.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$360.00
$475.00
20
(2)

Blasticidin S may inhibit Liprin-α3 expression by interfering with protein synthesis, potentially reducing the production of Liprin-α3.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

Mitomycin C might inhibit Liprin-α3 expression by crosslinking DNA, affecting transcription and potentially reducing Liprin-α3 synthesis.